NeuroVive Pharmaceutical (Sweden) Profile

2.27
SEK 0.06  2.71%
21%
6%

NeuroVive Pharmaceutical Summary

NeuroVive Pharmaceutical AB (NVP) is traded on Stockholm Stock Exchange in Sweden. It is located in Lund, and employs 15 people. The company currently falls under 'Small-Cap' category with current market capitalization of 143.84 M. NeuroVive Pharmaceutical AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 52.33 M outstanding shares. NEUROVIVE PHARMA has accumulated about 35.44 M in cash with (59.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Check NeuroVive Pharmaceutical Probability Of Bankruptcy

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 60.2%30 days 2.27  about 39.73%
Based on normal probability distribution, the odds of NeuroVive Pharmaceutical to move above current price in 30 days from now is about 39.73% (This NeuroVive Pharmaceutical AB probability density function shows the probability of NeuroVive Pharmaceutical Stock to fall within a particular range of prices over 30 days) .

NeuroVive Pharmaceutical Risk Profiles

Key Fundamentals

NeuroVive Pharmaceutical Against Markets

Current Ratings

NeuroVive Pharmaceutical 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 77% 
Equity ratings for NeuroVive Pharmaceutical AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
NeuroVive Pharmaceutical AB engages in the research, discovery, and development of mitochondrialprotecting pharmaceuticals in Sweden and Hong Kong. more
NameNeuroVive Pharmaceutical AB
Interim CEO and COOJan NilssonView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressLund,
ExchangeStockholm Stock Exchange
ISINSE0002575340
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.neurovive.com
Contact Number46 4 62 75 62 20
CurrencySEK - Swedish Kronor

Diversify with NeuroVive Pharmaceutical AB

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add NeuroVive Pharmaceutical AB to your portfolio

Directors

NeuroVive Pharmaceutical Corporate Directors
Please see also Stocks Correlation. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.